MRNA – Moderna, Inc.
Moderna, Inc.MRNA
$25.49Name : Moderna, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $9,858,054,144.00
EPSttm : -8.73
Moderna, Inc.
$25.49
0.82%$0.21Float Short %
17.58
Margin Of Safety %
Put/Call OI Ratio
0.69
EPS Next Q Diff
0.68
EPS Last/This Y
-0.84
EPS This/Next Y
2.63
Price
25.49
Target Price
44.81
Analyst Recom
2.83
Performance Q
-17.59
Relative Volume
0.8
Beta
1.87
Ticker: MRNA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-14 | MRNA | 26.79 | 0.72 | 0.29 | 833640 |
| 2025-04-15 | MRNA | 26.25 | 0.72 | 1.08 | 848814 |
| 2025-04-16 | MRNA | 24.99 | 0.72 | 0.26 | 856907 |
| 2025-04-17 | MRNA | 24.72 | 0.69 | 0.21 | 858254 |
| 2025-04-18 | MRNA | 24.72 | 0.69 | 0.22 | 858254 |
| 2025-04-21 | MRNA | 25.13 | 0.75 | 0.37 | 742449 |
| 2025-04-22 | MRNA | 25.72 | 0.73 | 0.48 | 765829 |
| 2025-04-23 | MRNA | 26.52 | 0.73 | 0.10 | 771891 |
| 2025-04-24 | MRNA | 27.21 | 0.74 | 0.14 | 771335 |
| 2025-04-25 | MRNA | 27.22 | 0.72080792465343 | 0.20297196892942 | 783637 |
| 2025-04-28 | MRNA | 27.46 | 0.72713846961069 | 0.27785959744723 | 763675 |
| 2025-04-29 | MRNA | 27.82 | 0.73 | 0.61 | 763834 |
| 2025-04-30 | MRNA | 28.54 | 0.73 | 0.68 | 770999 |
| 2025-05-01 | MRNA | 26.99 | 0.74 | 0.25 | 795926 |
| 2025-05-02 | MRNA | 27.59 | 0.70 | 0.23 | 839549 |
| 2025-05-05 | MRNA | 27.83 | 0.75 | 0.59 | 782609 |
| 2025-05-06 | MRNA | 24.43 | 0.74 | 1.29 | 789786 |
| 2025-05-07 | MRNA | 24.06 | 0.75 | 0.20 | 823144 |
| 2025-05-08 | MRNA | 24.36 | 0.70 | 0.22 | 880335 |
| 2025-05-09 | MRNA | 24.25 | 0.66 | 0.31 | 911262 |
| 2025-05-12 | MRNA | 25.73 | 0.71 | 0.52 | 849948 |
| 2025-05-13 | MRNA | 25.5 | 0.69 | 0.52 | 873845 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-14 | MRNA | 26.80 | -1.0 | -856.9 | -10.18 |
| 2025-04-15 | MRNA | 26.24 | -1.0 | -382.6 | -10.18 |
| 2025-04-16 | MRNA | 25.19 | -0.9 | -164.5 | -10.11 |
| 2025-04-17 | MRNA | 24.72 | -0.9 | -382.8 | -10.11 |
| 2025-04-18 | MRNA | 24.72 | -0.9 | -604.9 | -10.12 |
| 2025-04-21 | MRNA | 25.11 | -0.8 | -800.0 | -10.12 |
| 2025-04-22 | MRNA | 25.74 | -0.8 | -891.7 | -10.12 |
| 2025-04-23 | MRNA | 26.54 | -1.0 | -957.3 | -10.15 |
| 2025-04-24 | MRNA | 27.39 | -1.2 | -949.7 | -10.16 |
| 2025-04-25 | MRNA | 27.22 | -1.2 | -541.0 | -10.16 |
| 2025-04-28 | MRNA | 27.46 | -1.2 | -696.2 | -10.17 |
| 2025-04-29 | MRNA | 27.82 | -1.2 | -739.0 | -10.17 |
| 2025-04-30 | MRNA | 28.54 | -1.2 | -865.0 | -10.21 |
| 2025-05-01 | MRNA | 27.03 | -1.2 | -91.0 | -10.21 |
| 2025-05-02 | MRNA | 27.61 | -1.2 | 26.8 | -10.21 |
| 2025-05-05 | MRNA | 27.84 | 10.8 | -868.8 | -10.02 |
| 2025-05-06 | MRNA | 24.40 | 11.0 | 173.6 | -10.11 |
| 2025-05-07 | MRNA | 24.06 | 11.0 | -700.2 | -10.11 |
| 2025-05-08 | MRNA | 24.37 | 11.0 | -968.2 | -10.12 |
| 2025-05-09 | MRNA | 24.25 | 11.0 | -794.0 | -10.12 |
| 2025-05-12 | MRNA | 25.70 | 11.0 | -1410.7 | -10.12 |
| 2025-05-13 | MRNA | 25.49 | 11.0 | -770.6 | -10.12 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-14 | MRNA | 0.43 | 7.34 | 14.58 |
| 2025-04-15 | MRNA | 0.43 | 7.34 | 14.58 |
| 2025-04-16 | MRNA | 0.43 | 7.34 | 14.58 |
| 2025-04-17 | MRNA | 0.43 | 7.34 | 14.58 |
| 2025-04-18 | MRNA | 0.43 | 7.34 | 14.58 |
| 2025-04-21 | MRNA | 0.43 | 7.63 | 14.58 |
| 2025-04-22 | MRNA | 0.43 | 7.63 | 14.58 |
| 2025-04-23 | MRNA | 0.43 | 7.63 | 14.58 |
| 2025-04-24 | MRNA | 0.43 | 7.63 | 14.58 |
| 2025-04-25 | MRNA | 0.43 | 7.63 | 14.58 |
| 2025-04-28 | MRNA | 0.43 | 7.60 | 16.48 |
| 2025-04-29 | MRNA | 0.43 | 7.60 | 16.48 |
| 2025-04-30 | MRNA | 0.43 | 7.60 | 16.48 |
| 2025-05-01 | MRNA | 0.43 | 7.60 | 16.48 |
| 2025-05-02 | MRNA | 0.43 | 7.60 | 16.48 |
| 2025-05-05 | MRNA | 0.43 | 8.91 | 16.48 |
| 2025-05-06 | MRNA | 0.43 | 8.91 | 16.48 |
| 2025-05-07 | MRNA | 0.43 | 8.91 | 16.44 |
| 2025-05-08 | MRNA | 0.43 | 8.91 | 16.44 |
| 2025-05-09 | MRNA | 0.43 | 8.91 | 16.44 |
| 2025-05-12 | MRNA | 0.43 | 3.93 | 17.58 |
| 2025-05-13 | MRNA | 0.43 | 3.93 | 17.58 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-2.52
Avg. EPS Est. Current Quarter
-2.98
Avg. EPS Est. Next Quarter
-1.84
Insider Transactions
0.43
Institutional Transactions
3.93
Beta
1.87
Average Sales Estimate Current Quarter
110
Average Sales Estimate Next Quarter
1147
Fair Value
Quality Score
43
Growth Score
39
Sentiment Score
1
Actual DrawDown %
94.9
Max Drawdown 5-Year %
-95
Target Price
44.81
P/E
Forward P/E
PEG
P/S
3.1
P/B
0.98
P/Free Cash Flow
EPS
-8.72
Average EPS Est. Cur. Y
-10.12
EPS Next Y. (Est.)
-7.49
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-105.67
Relative Volume
0.8
Return on Equity vs Sector %
-57
Return on Equity vs Industry %
-40.1
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.06
EBIT Estimation
-770.6
Moderna, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 5800
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
stock quote shares MRNA – Moderna, Inc. Stock Price stock today
news today MRNA – Moderna, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MRNA – Moderna, Inc. yahoo finance google finance
stock history MRNA – Moderna, Inc. invest stock market
stock prices MRNA premarket after hours
ticker MRNA fair value insiders trading